Abstract
Purpose of Review
In this review, we seek to analyze the most novel findings recently published in the literature on sleep and dementia.
Recent Findings
The degeneration of suprachiasmatic nucleus and prefrontal cortex in dementia disrupts sleep-wake rhythmicity and contributes to cognitive deterioration in Alzheimer’s Dementia (AD), respectively. Sleep deprivation increases amyloid-β production and decreases its clearance. Short and long duration of sleep increase risk of cognitive disorders. Studies suggest that obstructive sleep apnea accelerates amyloid deposition though intermittent hypoxia. Effect of CPAP on cognition is controversial. Subjects with severe daytime sleepiness or sleep-related movement disorder have a higher risk for vascular dementia.
Summary
These findings highlight the impact of sleep on dementia. Thus, the bi-directional link of sleep and neurodegenerative disease may influence each other in many ways that have important implications for the diagnosis and treatment of AD.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Wilmo A, Guerchet M, Ali GC, Wu YT, Prina AM, Winblad B, et al. World Alzheimer report. 2015. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 2017;13(1):1–7.
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63–75.e62.
Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342:373–7.
Cedernaes J, Osorio RS, Varga AW, Kam K, Schioth HB, Benedict C. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer’s disease. Sleep Med Rev. 2017;31:102–111.
Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA. Sleep disturbance in mild to moderate Alzheimer’s disease. Sleep Med. 2005;6(4):347–52.
Avidan AY. Sleep and neurologic problems in the elderly. Sleep Med Clin. 2006;1:273–92.
Row BW. Intermittent hypoxia and cognitive function: implications from chronic animal models. Adv Exp Med Biol. 2007;618:51–67.
Shi L, Chen SJ, Ma MY, Bao YP, Han Y, Wang YM, et al. Sleep disturbances increase the risk of dementia: A systematic review and meta-analysis. Sleep Med Rev. 2017. https://doi.org/10.1016/j.smrv.2017.06.010.
Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, et al. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. Am Geriatr Soc. 2008;56:2076–81.
Tsapanou A, Gu Y, Manly J, Schupf N, Tang M-X, Zimmerman M, et al. Daytime sleepiness and sleep inadequacy as risk factors for dementia. Dement Geriatr Cogn Dis Extra. 2015;5(2):286e95.
Osorio RS, Pirraglia E, Aguera-Ortiz LF, During EH, Sacks H, Ayappa I, et al. Greater risk of Alzheimer's disease in older adults with insomnia. J Am Geriatr Soc. 2011;59(3):559e62.
Musiek ES, Holtzman DM. Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science. 2016;354(6315):1004–8.
Wu YH, Swaab DF. The human pineal gland and melatonin in aging and Alzheimer’s disease. J Pineal Res. 2005;38:145e52.
Van Erum J, Van Dam D, De Deyn PP. Sleep and Alzheimer’s disease: a pivotal role for the suprachiasmatic nucleus. Sleep Med Rev. 2017. pii: S1087-0792(17)30105-3.
Thome J, Coogan AN, Woods AG, Darie CC, Häßler F. CLOCK genes and circadian rhythmicity in Alzheimer disease. J Aging Res. 2011;2011:383091.
Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A. Sundowning and circadian rhythms in Alzheimer’s disease. Am J Psychiatry. 2001;158:704e 11.
Pase MP, Himali JJ, Grima NA, Beiser AS, Satizabal CL, Aparicio HJ, Thomas RJ, Gottlieb DJ, Auerbach SH, Seshadri S. Sleep architecture and the risk of incident dementia in the community. Neurology 2017;89(12):1244–1250.
Buysse DJ, Germain A, Moul DE, Franzen PL, Brar LK, Fletcher ME, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med. 2011;171(10):887–95.
de Almondes KM, Costa MV, Malloy-Diniz LF, Diniz BS. Insomnia and risk of dementia in older adults: systematic review and meta-analysis. J Psychiatr Res. 2016;77:109–15.
Sterniczuk R, Theou O, Rusak B, Rockwood K. Sleep disturbance is associated with incident dementia and mortality. Curr Alzheimer Res. 2013;10(7):767e75.
Peter-Derex L, Yammine P, Bastuji H, Croisile B. Sleep and Alzheimer’s disease. Sleep Med Rev. 2015;19:29–38.
Cipriani G, Lucetti C, Danti S, Nuti A. Sleep disturbances and dementia. Psychogeriatrics. 2015;15:65–74.
Scullin MK, Bliwise DL. Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research. Perspect Psychol Sci. 2015;10:97–137.
Born J, Rasch B, Gais S. Sleep to remember. Neuroscientist. 2006;12:410e 24.
Ju YE, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology–a bidirectional relationship. Nat Rev Neurol. 2014;10:115–9.
Zhu B, Dong Y, Xu Z, Gompf HS, Ward SA, Xue Z, et al. Sleep disturbance induces neuroinflammation and impairment of learning and memory. Neu-robiol Dis. 2012;48(3):348e55.
Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9:119e128.
Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, et al. Neuronal activity regulates the regional vulnerability to amyloid-b deposition. Nat Neurosci. 2011;14:750e756.
Lucey BP, Bateman RJ. Amyloid-beta diurnal pattern: possible role of sleep in Alzheimer’s disease pathogenesis. Neurobiol Aging. 2014;35(Suppl 2):S29–34.
Wu YE, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology–a bidirectional relationship. Nat Rev Neurol. 2014;10:115–9.
Porter VR, Buxton WG, Avidan AY. Sleep, cognition and dementia. Curr Psychiatry Rep. 2015;17(12):97. https://doi.org/10.1007/s11920-015-0631-8. Review
Wu TY, Chen CP, Jinn TR. Alzheimer’s disease: aging, insomnia and epigenetics. Taiwan J Obstet Gynecol. 2010;49(4):468–72.
•• Mander BA, Winer JR, Jagust WJ, Walker MP. Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of alzheimer’s disease? Trends Neurosci. 2016;39:552–66. Insufficient sleep facilitates accumulation of amyloid-β (Aβ), potentially triggering earlier cognitive decline and conversion to AD. Novel findings of NREM sleep disruption which may serve as a new biomarker of AD.
Polsek D, Gildeh N, Cash D, Winsky-Sommerer R, Williams SCR, Turkheimer F, et al. Obstructive sleep apnoea and Alzheimer’s disease: in search of shared pathomechanisms. Neurosci Biobehav Rev. 2018;86:142-49.
Anderson KN, Hatfield C, Kipps C, Hastings M, Hodges JR. Disrupted sleep and circadian patterns in frontotemporal dementia. Eur J Neurol. 2009;16:317–23.
Merrilees J, Hubbard E, Mastick J, Miller BL, Dowling GA. Sleep in persons with frontotemporal dementia and their family caregivers. Nurs Res. 2014;63:129–36.
Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer’s disease: epidemiology, pathophysiology and treat ment. CNS Drugs. 2001;15:777–96.
Yamakawa M, Shigenobu K, Makimoto K, Canqun Zhu, Ashida N, Tabushi K. Environmental control interventions for frontotemporal dementia with reversed sleep-wake cycles. Am J Alzheimers Dis Other Demen. 2008;23:470–6.
Mayo MC, Bordelon Y. Dementia with Lewy bodies. Semin Neurol. 2014;34:182–8.
McCurry SM, Logsdon RG, Teri L, et al. Characteristics of sleep disturbance in community-dwelling Alzheimer’s disease patients. J Geriatr Psychiatry Neurol. 1999;12:53–9.
Potvin O, Lorrain D, Forget H, Dubé M, Grenier S, Préville M, et al. Sleep quality and 1-yearincident cognitive impairment in community-dwelling older adults. Sleep. 2012;35:491–9.
Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer’s disease and cognitive decline in older persons. Sleep. 2013;36:1027–32.
Yaffe K, Laffan AM, Harrison SL, Redline S, Spira AP, Ensrud KE, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA. 2011;306:613–9.
Osorio RS, Gumb T, Pirraglia E, Varga AW, Lu SE, Lim J, et al. Leep-disordered breathing advances cognitive decline in the elderly. Neurology. 2015;84(19):1964–71.
Blackwell T, Yaffe K, Laffan A, Redline S, Ancoli-Israel S, Ensrud KE, et al. Osteoporotic fractures in men study group associations between sleep-disordered breathing, nocturnal hypoxemia, and subsequent cognitive decline in older community-dwelling men: the osteoporotic fractures in men sleep study. J Am Geriatr Soc. 2015;63(3):453–61.
Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O. Sleep disordered breathing in community-dwelling el-derly. Sleep. 1991;14:486–95.
•• Yun CH, Lee HY, Lee SK, Kim H, Seo HS, Bang SA, et al. Amyloid burden in obstructive sleep apnea. J Alzheimers Dis. 2017;59(1):21. OSA accelerates amyloid deposition and may contribute to the development or progression of Alzheimer's disease.–9.
•• Liguori C, Mercuri NB, Izzi F, Romigi A, Cordella A, Sancesario G, et al. Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer’s Disease Biomarkers Changes. Sleep. 2017;40(5). https://doi.org/10.1093/sleep/zsx011. OSA may induce early but possibly CPAP-modifiable AD biomarkers changes.
Gozal D, Daniel JM, Dohanich GP. Behavioral and anatom ical correlates of chronic episodic hypoxia during sleep in the rat. J Neurosci. 2001;21(7):2442–50.
Ju YE, Finn MB, Sutphen CL, Herries EM, Jerome GM, Ladenson JH, et al. Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid. Ann Neurol. 2016;80:154–9.
• Cedernaes J, Osorio RS, Varga AW, Kam K, Schioth HB, Benedict C. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer’s disease. Sleep Med Rev. 2017;31:102–111. This review suggests findings which support the existence of a mechanistic interplay between AD pathogenesis and disrupted sleep-wake cycles, which is able to accelerate the development and progression of this disease.
Kylstra WA, Aaronson JA, Hofman WF, Schmand BA. Neuropsychological functioning after CPAP treatment in obstructive sleep apnea: a meta-analysis. Sleep Med Rev. 2013;17(5):341–7.
Matthews EE, Aloia MS. Cognitive recovery following positive airway pressure (PAP) in sleep apnea. Prog Brain Res. 2011;190:71e88.
Troussière A, Monaca Charley C, Salleron J, et al. Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2014;85:1405–8.
Bliwise DL. Alzheimer’s disease, sleep apnea and positive pressure therapy. Curr Treat Options Neurol. 2013;15:669–76.
Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11(3):157–65.
•• Wu L, Sun D, Tan Y. A systematic review and dose-response meta-analysis of sleep duration and the occurrence of cognitive disorders. Sleep Breath. 2017. https://doi.org/10.1007/s11325-017-1527-0. This study supports that the lowest incident risk of cognitive disorders was found at the sleep duration of 7–8 h per day.
• Shi L, Chen SJ, Ma MY, Bao YP, Han Y, Wang YM, et al. Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med Rev. 2017. https://doi.org/10.1016/j.smrv.2017.06.010. This meta-analysis suggests that sleep disturbances may predict the risk of incident dementia.
Lin CC, Chou CH, Fan YM, Yin JH, Chung CH, Chien WC, et al. Increased risk of dementia among sleep-related movement disorders: a population-based longitudinal study in Taiwan. Medicine. 2015;94(51):e2331.
Chang WP, Liu ME, Chang WC, Yang AC, Ku YC, Pai JT, et al. Sleep apnea and the risk of dementia: a population-based 5-year follow-up study in Taiwan. PLoS One. 2013;8(10):e78655.
Bhidayasiri R, Sringean J, Rattanachaisit W, Truong DD. The sleeping brain in Parkinson's disease: a focus on REM sleep behaviour disorder and related parasomnias for practicing neurologists. J Neurol Sci. 2017;374:32–7.
•• Chahine LM, Xie SX, Simuni T, Tran B, Postuma R, Amara A, et al. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. Parkinsonism Relat Disord. 2016;27:102–6. This study shows that RBD is common in early PD and predicts future cognitive decline, particularly in attention and memory domains.
Liu RY, Zhou JN, van Heerikhuize J, Hofman MA, Swaab DF. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab. 1999;84(1):323–7.
•• Najjar RP, Zeitzer JM. Temporal integration of light flashes by the human circadian system. J Clin Investig. 2016;126(3):938–47. This study demonstrated that intermittent light is more effective than continuous light at eliciting circadian changes and treating circadian disorders.
Ju YE, McLeland JS, Toedebusch CD, Xiong C, Fagan AM, Duntley SP, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013;70(5):587–93.
Westwood AJ, Beiser A, Jain N, Himali JJ, DeCarli C, Auerbach SH, et al. Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia. Neurology. 2017;88(12):1172–9.
McCurry SM, LaFazia DM, Pike KC, Logsdon RG, Teri L. Development and evaluation of a sleep education program for older adults with dementia living in adult family homes. Am J Geriatr Psychiatry. 2012;20(6):494–504.
van Maanen A, Meijer AM, van der Heijden KB, Oort FJ. The effects of light therapy on sleep problems: a systematic review and meta-analysis. Sleep Med Rev. 2015;29:52–62. This meta-analysis examines the effect of bright light therapy specifically on sleep.
Lim AS, Yu L, Kowgier M, Schneider JA, Buchman AS. Bennett. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. DAJAMA Neurol. 2013;70(12):1544–51.
Forbes D, Blake CM, Thiessen EJ, Peacock S, Hawranik P. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database Syst Rev. 2014;2:CD003946.
Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, et al. Cognitive effects of treating obstructive sleep apnea in Alzheimer’s disease: a randomized controlled study. J Am Geriatr Soc. 2008;56(11):2076–81.
Ooms S, Ju YE. Treatment of Sleep Disorders in Dementia. Curr Treat Options Neurol. 2016;18:40.
McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in Alzheimer’s disease. Cochrane Database Syst Rev. 2014;3:CD009178.
Xu J, Wang LL, Dammer EB, Li CB, Xu G, Chen SD, et al. Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials. Am J Alzheimer's Dis Other Demen. 2015;30(5):439–47.
Camargos EF, Louzada LL, Quintas JL, Naves JO, Louzada FM, Nobrega OT. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. Am J Geriatr Psychiatry. 2014;22(12):1565–74.
Scoralick FM, Louzada LL, Quintas JL, Naves JO, Camargos EF, Nobrega OT. Mirtazapine does not improve sleep disorders in Alzheimer’s disease: results from a double-blind, placebo-controlled pilot study. Psychogeriatrics. 2017;17(2):89–86.
Deschenes CL, McCurry SM. Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Rep. 2009;11(1):20–6.
Closser MH. Benzodiazepines and the elderly. A review of potential problems. J Subst Abus Treat. 1991;8(1–2):35–41.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Sleep and Neurological Disorders
Rights and permissions
About this article
Cite this article
Vaou, O.E., Lin, S.H., Branson, C. et al. Sleep and Dementia. Curr Sleep Medicine Rep 4, 134–142 (2018). https://doi.org/10.1007/s40675-018-0112-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40675-018-0112-9